BR0211780A - Composto, e, composição farmacêutica - Google Patents
Composto, e, composição farmacêuticaInfo
- Publication number
- BR0211780A BR0211780A BR0211780-0A BR0211780A BR0211780A BR 0211780 A BR0211780 A BR 0211780A BR 0211780 A BR0211780 A BR 0211780A BR 0211780 A BR0211780 A BR 0211780A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- cfh
- compounds
- hydrogen atom
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 208000006820 Arthralgia Diseases 0.000 abstract 1
- 208000000491 Tendinopathy Diseases 0.000 abstract 1
- 206010043255 Tendonitis Diseases 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 201000004415 tendinitis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMPOSTO, E, COMPOSIçãO FARMACêUTICA". Um composto da fórmula (I) em que R^ 1^ e R^ 2^, que podem ser o mesmo ou diferentes, é cada qual um átomo de hidrogênio ou um grupo CF~ 3~, CF~ 2~H ou CFH~ 2~, contanto que quando um de R^ 1^ ou R^ 2^ for um átomo de hidrogênio, o outro seja um grupo CF~ 3~, CF~ 2~H ou CFH~ 2~; e os sais, solvatos ou hidratos dos mesmos. Os compostos são inibidores de NMP potentes, que vantajosamente não causam tendinite em um modelo de animal relevante. é esperado que estes compostos sejam usados em medicina, especialmente quando for desejado evitar efeitos colaterais, tais que dor na junta.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0119396.0A GB0119396D0 (en) | 2001-08-09 | 2001-08-09 | Hydroxamic acid derivatives |
PCT/GB2002/003656 WO2003014101A1 (en) | 2001-08-09 | 2002-08-07 | Hydroxamic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211780A true BR0211780A (pt) | 2004-07-27 |
Family
ID=9920067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211780-0A BR0211780A (pt) | 2001-08-09 | 2002-08-07 | Composto, e, composição farmacêutica |
Country Status (21)
Country | Link |
---|---|
US (1) | US7015234B2 (pt) |
EP (1) | EP1414812B1 (pt) |
JP (1) | JP2005501090A (pt) |
KR (1) | KR20040035725A (pt) |
CN (1) | CN1275954C (pt) |
AT (1) | ATE318263T1 (pt) |
BR (1) | BR0211780A (pt) |
CA (1) | CA2456291A1 (pt) |
DE (1) | DE60209354T2 (pt) |
EA (1) | EA006877B1 (pt) |
ES (1) | ES2257561T3 (pt) |
GB (1) | GB0119396D0 (pt) |
HU (1) | HUP0401187A2 (pt) |
IL (1) | IL160266A0 (pt) |
MX (1) | MXPA04001212A (pt) |
NO (1) | NO20040551L (pt) |
NZ (1) | NZ531521A (pt) |
PL (1) | PL368228A1 (pt) |
PT (1) | PT1414812E (pt) |
WO (1) | WO2003014101A1 (pt) |
ZA (1) | ZA200401873B (pt) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
RU2210567C2 (ru) * | 1997-11-12 | 2003-08-20 | Дарвин Дискавери Лимитед | Производные гидроксамовой и карбоновой кислоты, имеющие mmp ингибирующую активность, и фармацевтическая композиция на их основе |
US6187924B1 (en) * | 1997-11-12 | 2001-02-13 | Darwin Discovery, Ltd. | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
AU775701B2 (en) * | 1999-02-08 | 2004-08-12 | G.D. Searle & Co. | Sulfamato hydroxamic acid metalloprotease inhibitor |
-
2001
- 2001-08-09 GB GBGB0119396.0A patent/GB0119396D0/en not_active Ceased
-
2002
- 2002-08-07 JP JP2003519051A patent/JP2005501090A/ja active Pending
- 2002-08-07 WO PCT/GB2002/003656 patent/WO2003014101A1/en active IP Right Grant
- 2002-08-07 PL PL02368228A patent/PL368228A1/xx not_active Application Discontinuation
- 2002-08-07 CN CNB028200225A patent/CN1275954C/zh not_active Expired - Fee Related
- 2002-08-07 US US10/485,905 patent/US7015234B2/en not_active Expired - Fee Related
- 2002-08-07 PT PT02747621T patent/PT1414812E/pt unknown
- 2002-08-07 IL IL16026602A patent/IL160266A0/xx unknown
- 2002-08-07 BR BR0211780-0A patent/BR0211780A/pt not_active IP Right Cessation
- 2002-08-07 EP EP02747621A patent/EP1414812B1/en not_active Expired - Lifetime
- 2002-08-07 AT AT02747621T patent/ATE318263T1/de not_active IP Right Cessation
- 2002-08-07 KR KR10-2004-7001959A patent/KR20040035725A/ko not_active Application Discontinuation
- 2002-08-07 CA CA002456291A patent/CA2456291A1/en not_active Abandoned
- 2002-08-07 EA EA200400287A patent/EA006877B1/ru unknown
- 2002-08-07 NZ NZ531521A patent/NZ531521A/en unknown
- 2002-08-07 DE DE60209354T patent/DE60209354T2/de not_active Expired - Fee Related
- 2002-08-07 MX MXPA04001212A patent/MXPA04001212A/es unknown
- 2002-08-07 HU HU0401187A patent/HUP0401187A2/hu unknown
- 2002-08-07 ES ES02747621T patent/ES2257561T3/es not_active Expired - Lifetime
-
2004
- 2004-02-06 NO NO20040551A patent/NO20040551L/no not_active Application Discontinuation
- 2004-03-08 ZA ZA200401873A patent/ZA200401873B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1414812A1 (en) | 2004-05-06 |
IL160266A0 (en) | 2004-07-25 |
CN1568320A (zh) | 2005-01-19 |
DE60209354T2 (de) | 2006-10-19 |
NO20040551L (no) | 2004-05-10 |
MXPA04001212A (es) | 2004-07-08 |
HUP0401187A2 (hu) | 2004-12-28 |
NZ531521A (en) | 2005-06-24 |
ATE318263T1 (de) | 2006-03-15 |
GB0119396D0 (en) | 2001-10-03 |
KR20040035725A (ko) | 2004-04-29 |
CA2456291A1 (en) | 2003-02-20 |
EA200400287A1 (ru) | 2004-06-24 |
WO2003014101A1 (en) | 2003-02-20 |
ES2257561T3 (es) | 2006-08-01 |
CN1275954C (zh) | 2006-09-20 |
PL368228A1 (en) | 2005-03-21 |
PT1414812E (pt) | 2006-05-31 |
EA006877B1 (ru) | 2006-04-28 |
ZA200401873B (en) | 2005-03-08 |
DE60209354D1 (de) | 2006-04-27 |
US7015234B2 (en) | 2006-03-21 |
EP1414812B1 (en) | 2006-02-22 |
US20040192733A1 (en) | 2004-09-30 |
JP2005501090A (ja) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9913592A (pt) | Compostos, processo de preparação dos compostos, e, composições farmacêuticas | |
NO308736B1 (no) | 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse | |
BR0111596A (pt) | Composto e seu uso, processo para sua produção, composição farmacêutica e processo e método para prevenir ou tratar doenças | |
BR0210297A (pt) | Derivados de n-arilfenilacetamida e composição farmacêutcia contendo os mesmos | |
BR0210384A (pt) | Heteroarilas multicìclicas substituìdas por quinuclidinas para o tratamento de doença | |
BR0213877A (pt) | Compostos orgânicos | |
BR0207025A (pt) | Derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo | |
BR9914451A (pt) | Composto de oxazol, processo para sua preparação, composição farmacêutica compreendendo dito composto, uso da composição e métodos de tratamento | |
DK1140918T3 (da) | Thrombininhibitorer | |
BG66094B1 (bg) | Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства | |
BR0110998A (pt) | Derivados de fenilglicina | |
BR0312129A (pt) | Derivados de espiroindolinapiperidina | |
BR0307409A (pt) | Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico | |
BR9813390A (pt) | Composto, processo para a preparação do mesmo, e uso do mesmo, composição farmacêutica, processo para a preparação da mesma, e, processo para efetuar a imunossupressão | |
BR0214031A (pt) | Compostos de heteroarila azabicìclico substituìdos para o tratamento de doenças | |
BR0214160A (pt) | Triazolas substituìdas com fenila e sua utilização como inibidores seletivos da akl5 quinase | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
BR0309188A (pt) | Compostos pirazolo como agentes antiinflamatórios e analgésicos | |
BRPI0417948A (pt) | derivados de quinuclidina substituìda por bicicloheterociclo fundido | |
BR0315320A (pt) | Composto ou sais farmaceuticamente aceitáveis dos mesmos, uso de um composto, composição farmacêutica, e, métodos para a terapia de dor em um animal de sangue quente e para produzir um composto | |
BR0102377A (pt) | Inibidores de não-nucleosìdeo transcriptase reversa | |
BR0207795A (pt) | Derivados de ácido alcoxicarbonilamino benzóico ou alcoxicarbonilamino tetrazolil fenila como antagonistas de ip | |
BR0106248A (pt) | Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BR9905974A (pt) | Derivados de ácido aril carboxìlico e tetrazol | |
DK0937043T3 (da) | Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |